Data study · October 2026
Oura and Whoop
- Question
Does paying for a wearable change how people live?
- Headline finding
From 2020 to 2024 the share of US adults using a wearable rose from 30.2% to 41.1%, and the share meeting the aerobic activity guideline went from 47.9% to 48.0%. Oura keeps 85% of paid members for a year. I found no figure in the coverage of its IPO filing for whether members sleep or move more.
- My recommendation
Turn Advisor into a weekly plan and publish the share of members whose sleep or activity improved after 90 days.
- Tools
- CSV tables with a source URL on every row
- JavaScript on Node for the derived rates
- D3.js for the first dashboard
- React and SVG for the charts on this page
The question
- The client
Oura’s leadership. Oura postponed its IPO on September 29, 2026, with 5.7 million paid members and 90% revenue growth expected for fiscal 2026. Whoop is the comparison, a band sold only with a membership, with more than 2.5 million members.
- The decision they face
What should Oura build and report so that tracking turns into a lasting change in how members sleep and move?
The data, 2 tables from 39 sources
metrics.csv74 rows
Every figure in the study, one per row. It covers growth at Oura, Whoop and Garmin, US surveys of wearable use and activity, trial results on activity and sleep, and three Duolingo rows that tie back to my streaks study.
- Where it came from
- Press coverage of Oura’s S-1, company press releases, Garmin’s SEC 8-K filings, Pew, the HINTS and NHIS surveys, and peer-reviewed meta-analyses.
- Why I chose it
- Each figure has an ID and a source URL, so the code and a reader can go to the exact row.
- What it cannot tell us
- What happens to one person. The survey rows are population totals, and the trial rows are results I took from published papers. The Oura rows cite press coverage of the S-1, and none cites the filing directly.
variables.csv6 rows
Six product features scored 0 to 2 for Oura, Whoop, Apple Watch, Fitbit and Garmin.
- Where it came from
- My own coding from product pages and press releases as of October 2026, with a link to the research behind each feature.
- Why I chose it
- It puts Oura next to Whoop feature by feature. Oura totals 7 of 12 and Whoop 11, and the options aim at the gaps.
- What it cannot tell us
- Stand as measurement. The scores are judgment, and each row links its research so a reader can disagree. The table holds no URL for the product pages I read.
The 39 sources behind metrics.csv
metrics.csv holds figures from 39 sources. Each one is listed with the rows it supplies and what they cover. 19 of them carry figures a company reported about itself.
Show the 39 sources
3 rows · growth
A company’s own figures
1 row · growth
A company’s own figures
3 rows · growth
A company’s own figures
Oura press release, Business Wire
2 rows · growth
A company’s own figures
4 rows · growth, engagement
A company’s own figures
1 row · growth
A company’s own figures
1 row · engagement
A company’s own figures
1 row · engagement
A company’s own figures
1 row · valuation
Forbes Australia (Reuters calculation)
1 row · valuation
1 row · valuation
1 row · pricing
A company’s own figures
1 row · engagement
A company’s own figures
Oura press release via Silicon UK
1 row · engagement
A company’s own figures
2 rows · growth
A company’s own figures
3 rows · growth, valuation
1 of 3 rows are a company’s own figures
1 row · pricing
A company’s own figures
Garmin 8-K Ex. 99.1, FY2024 results
2 rows · growth
A company’s own figures
Garmin 8-K Ex. 99.1, FY2025 results
1 row · growth
A company’s own figures
1 row · growth
A company’s own figures
1 row · pricing
A company’s own figures
3 rows · wearable use
6 rows · wearable use
1 row · wearable use
Endeavour Partners via MobiHealthNews
1 row · abandonment
Endeavour Partners via NBC News
1 row · abandonment
1 row · abandonment
NHIS via Healthy People 2030 PA-02
2 rows · activity guideline
1 row · activity guideline
Ferguson et al. 2022, Lancet Digital Health
3 rows · trial outcomes
Ferguson et al. 2022 via Patient Care
3 rows · trial outcomes
6 rows · effects after a program ends
Brickwood et al. 2019, JMIR mHealth
4 rows · tracker alone and with a program
1 row · trial outcomes
Lai et al. 2022, Nursing & Health Sciences
1 row · sleep
1 row · sleep
Comas et al., RCT with actigraphy
1 row · sleep
Hartman et al. 2022, JMIR mHealth
2 rows · tracker alone and with a program
Duolingo Q2 2026 shareholder letter
3 rows · Duolingo tie-in
A company’s own figures
The process
One row per figure
Each figure went into a row of its own with a source name, a URL, the date I retrieved it and a flag for whether the company reported it. That came to 74 rows in metrics.csv from 39 source pages.
Parse
51 of the 74 rows have a comma inside a field, such as “Met aerobic physical activity guideline, age-adjusted”. Both files also use CRLF line endings. The parser reads quoted fields cell by cell and drops the carriage returns.
Join
Wearable use comes from HINTS and the activity guideline comes from NHIS. I joined the two on year. Both cover 2020 and 2024, and only HINTS has a 2022 figure.
Assumptions
Some sources gave a figure in words. Whoop’s member count was “more than 2.5M” and went in as 2.5. Oura’s share of first-time wearable buyers was “about a third” and went in as 33. Rows M01 to M03, the umbrella review’s extra steps and minutes a day, are marked approximate. The HINTS abstract gives daily use without naming its base. The table reads it as a share of all adults, so daily use stays out of the findings on this page.
Check
Oura’s nine-month revenue shows up in several press reports, so I checked it two ways. Hardware plus membership comes to $1,214.5 million against $1,210 million reported. Fiscal 2025 plus the nine-month change gives $1,420.3 million for the trailing year against $1,430 million reported. The larger gap is 0.7%, which fits rounding in the coverage.
One year before and after the join.
metric_id,metric,value,unit,period,source_name
S06,Use a wearable device to track health,41.1,%,2024,HINTS via Pedroso et al. 2026
S08,Use a wearable every day (share of all adults),18.5,%,2024,HINTS via Pedroso et al. 2026
N02,"Met aerobic physical activity guideline, age-adjusted",48.0,%,2024,NHIS via Healthy People 2030 PA-02{
"year": "2024",
"use": 41.1,
"daily": 18.5,
"aerobic": 48
}The first two rows are HINTS and the third is NHIS. The comma inside the third metric name is why the parser reads quoted fields.
The code for the key steps
export function parseCsv(text) {
const records = [];
let cells = [];
let cell = "";
let quoted = false;
for (let i = 0; i < text.length; i++) {
const ch = text[i];
if (quoted) {
if (ch === '"' && text[i + 1] === '"') {
cell += '"';
i++;
} else if (ch === '"') quoted = false;
else cell += ch;
} else if (ch === '"') quoted = true;
else if (ch === ",") {
cells.push(cell);
cell = "";
} else if (ch === "\n") {
cells.push(cell);
records.push(cells);
cells = [];
cell = "";
} else if (ch !== "\r") cell += ch;
}
if (cell !== "" || cells.length) records.push([...cells, cell]);
const [cols, ...rows] = records;
return rows.map((row) => {
if (row.length !== cols.length) throw new Error(`Expected ${cols.length} cells, got ${row.length}: ${row.join(",")}`);
return Object.fromEntries(cols.map((col, i) => [col, row[i]]));
});
}export function trend(metrics) {
const v = pick(metrics);
return [
{ year: "2020", use: v("S04"), daily: v("S07"), aerobic: v("N01") },
{ year: "2022", use: v("S05"), daily: null, aerobic: null },
{ year: "2024", use: v("S06"), daily: v("S08"), aerobic: v("N02") },
];
}export function headline(metrics) {
const v = pick(metrics);
return {
aerobic_change_pts: Math.round((v("N02") - v("N01")) * 10) / 10,
walk_retained_pct: (v("M09") / v("M07")) * 100,
daily_share_2020: (v("S07") / v("S04")) * 100,
daily_share_2024: (v("S08") / v("S06")) * 100,
shared_adults_2024: (v("S10") / 100) * v("S06"),
whoop_per_member: v("W02") / v("W01"),
duo_dau_mau: (v("D01") / v("D02")) * 100,
};
}Dead ends
Google Trends
I left Google Trends out because the research workspace could not reach it.
No 2022 point for activity
The Healthy People page has no 2022 value for the aerobic guideline. The 2022 wearable figure of 36.36% comes from a separate analysis of the same HINTS survey, so the comparison runs from 2020 to 2024.
The 3 findings that change the decision
Finding 1
+0.1 points
Change in adults meeting the aerobic guideline, 2020 to 2024
From 2020 to 2024 the share of US adults using a wearable rose from 30.2% to 41.1%, and the share meeting the aerobic activity guideline went from 47.9% to 48.0%.
Dataset metrics.csv
Query derive.mjs, trend()Wearable use rose from 30.2% to 41.1%. The share meeting the activity guideline moved 0.1 points
Wearable use is from HINTS. Meeting the aerobic guideline is from NHIS, age-adjusted. They are two different surveys, and population totals cannot show what happens to one user. NHIS has no 2022 value on the Healthy People page, so each line has two points.
- Meet the aerobic guideline
- Use a wearable
Source: metrics.csv, derive.mjs, trend().
Show the numbers as a table
Year Meet the aerobic guideline Use a wearable 2020 47.9 30.2 2024 48.0 41.1 Finding 2
54%
Share of the end-of-program walking effect left at long follow-up
In a meta-analysis of mobile health activity trials, only 54% of the walking effect was left at follow-ups more than six months after a program ended.
Dataset metrics.csv
Query derive.mjs, headline()Only 54% of the walking effect is left after a program ends
Standardized mean difference (SMD) against control, pooled in one meta-analysis (Monninghoff et al. 2021, JMIR). Around 0.2 is small and 0.5 is medium. Few trials report long follow-up, so the later bars rest on less data.
Walking effect against control (SMD)
Source: metrics.csv, derive.mjs, fade().
Show the numbers as a table
When the effect was measured Walking effect against control (SMD) Moderate-to-vigorous activity effect (SMD) Trials behind it End of program 0.46 0.28 117 mHealth trials Up to 6 months after 0.26 0.20 33 trials with short follow-up More than 6 months after 0.25 0.19 8 trials with long follow-up Finding 3
1.9x
Activity gain with a program around the tracker over the tracker alone, 0.33 against 0.17 SMD
Trials that put a program around the tracker raised moderate-to-vigorous activity about twice as much as the tracker alone. The tracker-alone result was too small to rule out chance.
Dataset metrics.csv
Query derive.mjs, design()A program around the tracker moved activity about twice as much as the tracker alone
Subgroups of one review of consumer trackers (Brickwood et al. 2019, JMIR mHealth). Each group was compared with a control group, and the tracker-alone result was not statistically significant. SMD is the standardized mean difference, where around 0.2 is small and 0.5 is medium. In the review a program meant added support such as counseling or financial incentives. Trackers that came with app messages or emails counted as tracker alone.
Effect against control (SMD)
Source: metrics.csv, derive.mjs, design().
Show the numbers as a table
Outcome and design Effect against control (SMD) Source row Note in the table MVPA, tracker plus program 0.33 M16 None MVPA, tracker alone 0.17 M15 Not significant (P = .05) Daily steps, tracker plus program 0.26 M14 None Daily steps, tracker alone 0.20 M13 28 RCTs, 3,646 adults
My recommendation
Turn Advisor into a weekly plan, and publish how many members sleep or move more after 90 days.
- A
Turn Advisor into a weekly plan
Each week Advisor picks one behavior from the member’s own sleep and Readiness data. It sets a target for that week and checks in midway.
- Evidence
- Findings 2 and 3. Trials that put a program around the tracker raised moderate-to-vigorous activity about twice as much as the tracker alone, and the walking effect fades once a program ends. On my 0-to-2 scale for coaching, Oura scores 1 and Whoop and Fitbit score 2.
- Main risk
- That result comes from subgroups of one review, and the tracker-alone result beside it was not significant. The programs in that review added support such as counseling or financial incentives. App messages counted as tracker alone, so an Advisor plan may land nearer the tracker-alone result.
- B
Publish a behavior-change number
Report the share of members whose sleep time or active minutes improved after 90 days, beside the 85% retention figure.
- Evidence
- Finding 1 and Oura’s own funnel. Oura reports 3.6 million rings sold in a year, 94% of activations turning into paid members, 85% of paid members kept for a year and a median 23 hours a day of wear. Its closest figure to an outcome is a survey where 56% of Advisor users said it helped them act.
- Main risk
- Oura would report the number itself. 19 of the 22 Oura rows in this study already come from the company, and the 56% survey has no outcome data behind it.
- Two findings back the weekly plan. A program around the tracker moved activity about twice as much as the tracker alone, and the effect faded once the program ended, so the plan has to keep running.
- The 90-day number tells Oura and its members whether the plan works. Today the closest thing Oura has is a survey where members said Advisor helped.
- That number should go out with its method, since Oura would be grading itself.
Limits and next steps
What the data cannot support
- Population totals cannot show what happens to one user, and wearable use and the activity guideline come from two different surveys.
- No row here compares people who pay a subscription with people who do not, and none of the trial rows names Oura or Whoop.
- The Oura rows cite press coverage of the S-1. I found no behavior outcome in that coverage, which is a weaker claim than saying the filing has none.
- 31 of the 74 rows in metrics.csv are flagged as reported by the company they describe, including every Oura engagement figure.
- Finding 2 compares different sets of trials. The end-of-program effect pools 117 mHealth trials, and the later points rest on 33 trials with short follow-up and 8 trials with long follow-up.
- The feature scores are my own judgment.
- Every row was retrieved on October 31, 2026, so nothing after that date is here.
What I would test with more access
- With HINTS microdata and survey weights I would link wearable use and activity for the same person.
- With Oura’s own data I would measure the number option B asks for, the share of members whose sleep time or active minutes improved after 90 days.
- I would add Google Trends search interest, which I could not reach, and source the Oura rows from the S-1 itself.
TL;DR
Studied
Whether paying for a wearable changes how people live, read from US surveys and activity trials.
Found
From 2020 to 2024, wearable use rose from 30.2% to 41.1% and adults meeting the activity guideline went from 47.9% to 48.0%.
By the numbers
- Change in adults meeting the guideline
- +0.1 points
- Of the walking effect left at long follow-up
- 54%
- Paid Oura members kept for a year
- 85%
The catch
Wearable use and the activity guideline come from two different surveys, so neither shows what one user did.
Next
With person-level HINTS survey data, link wearable use and activity for the same person.